Candel Therapeutics

formerly ADVANTAGENE, INCIPO

Candel Therapeutics is a biotech company in Needham, United States, founded in 2020. It has raised $180.0M across 3 rounds, most recently a $100.0M Corporate Round in February 2026.

Pioneering Precision Viral Immunotherapy for Patients Fighting Solid Tumors

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$180.0M
Last Round
$100.0M Corporate RoundFeb 2026
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Candel Therapeutics is a clinical-stage biopharmaceutical company developing off-the-shelf multimodal viral immunotherapies for solid tumors. Its platforms are designed to cause in-situ immunization by inducing tumor cell lysis and stimulating both innate and adaptive immune responses. Candel's investigational therapies target durable clinical benefit across multiple cancer indications, including prostate cancer, lung cancer, and glioblastoma.

Summary

It lists 11–50 employees. It has raised $180.0M in total across 3 rounds, most recently a $100.0M Corporate Round in Feb 2026. Investors include Trinity Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundFeb 2026
$100.0M

Sign up to see all 5 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Candel Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/candel-therapeutics"><img src="https://indexed.vc/api/badge/company/candel-therapeutics" alt="Candel Therapeutics on Indexed.vc" width="260" height="76" /></a>